Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients

Authors

  • Jianling Liu Department of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Haichen Wang Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Ziyan Huang Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Xiaoyan Tao Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Jun Li Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Yongmei Hu Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Qingya Dou Department of Infection Control Center, Xiangya Hospital, Central South University, Changsha, Hunan, China
  • Mingxiang Zou Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China

DOI:

https://doi.org/10.3855/jidc.11189

Keywords:

Klebsiella pneumoniae bacteremia, carbapenem-resistant, mortality, risk factors

Abstract

Introduction: Carbapenem-resistant Klebsiella pneumoniae (KP) serves as a major threat to onco-hematological patients, resulting in great morbidity and mortality. The purpose of our study was to identify the risk factors for KP bloodstream infections (BSIs) and mortality in onco-hematological patients.

Methodology: A retrospective observation study was conducted on KP BSIs in the onco-hematology departments at Xiangya hospital from January 2014 to September 2018. Multivariate analysis was employed to identify the independent risk factors for carbapenem-resistant (CR) KP BSIs and related mortality.

Results: A total of 89 strains of KP were analyzed in our study, in which 20 strains were CRKP. The only risk factor for CRKP BSI was carbapenem exposure within 30 days before the onset of BSIs (HR 25.122). The 30-day mortality was 24.7%. CRKP caused more mortality than carbapenem-susceptible KP (55.0% vs 15.9%, P = 0.001). In the multivariate analysis, unresolved neutropenia (HR 16.900), diarrhea (HR 3.647) and RDW > 14% (HR 6.292) were independent risk factors for mortality, and appropriate empirical therapy (HR 0.164) was protective against mortality.

Conclusions: Our findings showed that carbapenem resistance was spreading in our setting, and a precise combination of antibiotics covering the common pathogen is crucial to improving patient survival.

Downloads

Published

2019-05-31

How to Cite

1.
Liu J, Wang H, Huang Z, Tao X, Li J, Hu Y, Dou Q, Zou M (2019) Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients. J Infect Dev Ctries 13:357–364. doi: 10.3855/jidc.11189

Issue

Vol. 13 No. 05: May 2019

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC